Application of organoid culture from HPV18 ‐positive small cell carcinoma of the uterine cervix for precision medicine
Cancer Medicine · 2023
DOI: 10.1002/cam4.5588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Misako Kusakabe und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Small Cell, Uterine Cervical Neoplasms, Papillomavirus Infections, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Small cell carcinoma of the uterine cervix (SCCC) is a rare and highly malignant human papillomavirus (HPV)‐associated cancer in which human genes related to the integration site can serve as a target for precision medicine. The aim of our study was to establish a workflow for precision medicine of HPV‐associated cancer using patient‐derived organoid.
Methods
Organoid was established from the biopsy of a patient diagnosed with HPV18‐positive SCCC. Therapeutic targets were identified by whole exome sequencing (WES) and RNA‐seq analysis. Drug sensitivity testing was performed using organoids and organoid‐derived mouse xenograft model.
Results
WES revealed that both the original tumor and organoid had 19 somatic variants in common, including the KRAS p.G12D pathogenic variant. Meanwhile, RNA‐seq revealed that HPV18 was integrated into chromosome 8 at 8q24.21 with increased expression of the proto‐oncogene MYC . Drug sensitivity testing revealed that a KRAS pathway inhibitor exerted strong anti‐cancer effects on the SCCC organoid compared to a MYC inhibitor, which were also confirmed in the xenograft model.
Conclusion
In this study, we confirmed two strategies for identifying therapeutic targets of HPV‐derived SCCC, WES for identifying pathogenic variants and RNA sequencing for identifying HPV integration sites. Organoid culture is an effective tool for unveiling the oncogenic process of rare tumors and can be a breakthrough for the development of precision medicine for patients with HPV‐positive SCCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba, Japan.
- Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.
- CBBD-OIL, AIST-Waseda University, Tokyo, Japan.
- Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Ayumi Taguchi, Ryota Wagatsuma, Kohei Yamaguchi, Kenbun Sone, Katsutoshi Oda, Yoshitaka Hippo
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Kusakabe, M., Taguchi, A., Tanikawa, M., Hoshi, D., Tsuchimochi, S., Qian, X., Toyohara, Y., Kawata, A., Wagatsuma, R., Yamaguchi, K., Yamamoto, Y., Ikemura, M., Sone, K., Mori-Uchino, M., Matsunaga, H., Tsuruga, T., Nagamatsu, T., Kukimoto, I., Wada-Hiraike, O., …, & Osuga, Y. (2023). Application of organoid culture from HPV18 ‐positive small cell carcinoma of the uterine cervix for precision medicine. Cancer Medicine. https://doi.org/10.1002/cam4.5588
Vancouver
Kusakabe M, Taguchi A, Tanikawa M, Hoshi D, Tsuchimochi S, Qian X, et al. Application of organoid culture from HPV18 ‐positive small cell carcinoma of the uterine cervix for precision medicine. Cancer Medicine. 2023. doi:10.1002/cam4.5588
BibTeX
@article{Kusakabe2023,
author = {Kusakabe, Misako and Taguchi, Ayumi and Tanikawa, Michihiro and Hoshi, Daisuke and Tsuchimochi, Saki and Qian, Xi and Toyohara, Yusuke and Kawata, Akira and Wagatsuma, Ryota and Yamaguchi, Kohei and Yamamoto, Yoko and Ikemura, Masako and Sone, Kenbun and Mori-Uchino, Mayuyo and Matsunaga, Hiroko and Tsuruga, Tetsushi and Nagamatsu, Takeshi and Kukimoto, Iwao and Wada-Hiraike, Osamu and Kawazu, Masahito and Ushiku, Tetsuo and Takeyama, Haruko and Oda, Katsutoshi and Kawana, Kei and Hippo, Yoshitaka and Osuga, Yutaka},
title = {Application of organoid culture from HPV18 ‐positive small cell carcinoma of the uterine cervix for precision medicine},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5588}
}
EUVIMED